4. Del Pozo E., Barrios M. and Baeyens J. M. (1996) The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced
place preference conditioning in mice. Psychopharmacology 125, 209–213.
5. Di Chiara G. and North R. A. (1992) Neurobiology of opiate abuse. Trends pharmac. Sci. 13, 185–193.
6. Funada M, Suzuki T. and Misawa M. (1995) Role of mesolimbic dopamine system in morphine dependence. Ann. Psychiatry 5, 223–237.
7. Gallangher M. J., Huang H., Prichett D. B. and Lynch D. R. (1996) Interactions between ifenprodil and the NR2B subunit of the N-methyl-d-aspartate
receptor. J. biol. Chem. 271, 9603–9611.
8. Goebel D. J. and Poosch M. S. (1999) NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of
NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A. Molec. Brain Res. 69, 164–170.
9. Haley M. J. and McCormick W. G. (1957) Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmac.
12, 12–15.
10. Hayes B. A. and Balster R. L. (1985) Anticonvulsant properties of phencyclidine-like drugs in mice. Eur. J. Pharmac. 117, 121–125.
11. Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M., Akazawa C., Shigemoto R., Mizuno N., Masu M. and Nakanishi S. (1993)
Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits. J. biol. Chem. 268, 2836–2843.
12. Jeziorski M., White F. J. and Wolf M. E. (1994) MK801 prevents the developmennt of behavioral sensitization during repeated morphine administration.
Synapse 16, 137–147.
13. Kalivas P. W. (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18, 75–113.
14. Koob G. F. (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends pharmac. Sci. 13, 177–184.
15. Krebs M. O., Densce J. M., Kemei M. L., Gauchy C., Godeheu G., Cheramy A. and Glowinsky J. (1991) Glutamatergic control of dopamine release in the
rats striatum: evidence for presynaptic N-methyl-d-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56, 81–85.
16. Kutsuwada T., Kashiwabuchi N., Mori H., Sakimura K., Kushiya E., Araki K., Meguro H., Masaki H., Kumanishi T., Arakawa M. and Mishina M. (1992)
Molecular diversity of the NMDA receptor channel. Nature 358, 36–41.
17. Lau L.-F. and Huganir R. L. (1995) Differential tyrosine phosphorylation of N-methyl-d-aspartate receptor subunits. J. biol. Chem. 270, 20,036–20,041.
18. Lipton S. A. and Rosenberg P. A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330, 613–622.
19. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. biol. Chem. 193, 265–275.
20. Madison D. V., Malenka R. C. and Nicoll R. A. (1991) Mechanisms underlying long-term potentiation of synaptic transmission. A. Rev. Neurosci. 14,
379–397.
21. McBain C. J. and Mayer M. L. (1994) N-methyl-d-aspartate receptor structure and function. Physiol. Rev. 74, 723–760.
22. Meguro H., Mori H., Araki K., Kushiya E., Kutsuwada T., Yamazaki M., Kumanishi T., Arakawa M., Sakimura K. and Mishina M. (1992) Functional
characterization of a heteromeric NMDA receptor channel expressed from cloned cDNA. Nature 357, 70–74.
23. Meldrum B. and Garthwaite J. (1990) Excitatory amino acid neurotoxicity and neurogenerative disease. Trends pharmac. Sci. 11, 379–387.
24. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B. and Seeberg P. H. (1992) Heteromeric NMDA
receptors: Molecular and functional distinction of subtypes. Science 256, 1217–1221.
25. Monyer H., Burnashev N., Laurie D., Sakmann B. and Seeberg P. H. (1994) Developmental and regional expression in the rat brain and functional
properties of four NMDA receptors. Neuron 12, 529–540.
26. Mori H., Yamakura T., Masaki H. and Mishina M. (1993) Involvement of the carboxyl-terminal region in modulation by TPA of the NMDA receptor
channel. NeuroReport 4, 519–522.
27. Palmer G. C., Harris E. W., Ray R., Stagnitto M. L. and Schmiesig R. J. (1992) Classification of compounds for prevention of NMDA-induced seizures/
mortality, or maximal electroshock and pentylenetetrazole seizures in mice and antagonism of MK801 binding in vitro. Archs int. Pharmacodyn. The ́r.
317, 16–34.
28. Rostas J. A., Brent V. A., Voss K., Errington M. L., Bliss T. V. P. and Gurd J. W. (1996) Enhanced tyrosine phosphorylation of the 2B subunit of the
N-methyl-d-aspartate receptor in long-term potentiation. Proc. natn. Acad. Sci. USA 93, 10,452–10,456.
29. Sheng M., Cummings J., Roldan L. A., Jan Y. N. and Jan L. Y. (1994) Changing subunit composition of heteromeric NMDA receptors during
development of rat cortex. Nature 368, 144–147.
30. Standaert D. G., Testa C. M., Young A. B. and Penney J. B. Jr (1994) Organization of N-methyl-d-aspartate glutamate receptor gene expression in the
basal ganglia of the rat. J. comp. Neurol. 343, 1–16.
31. Suzuki T., Masukawa Y. and Misawa M. (1990) Drug interactions in the reinforcing effects of over-the-counter cough syrups. Psychopharmacology 102,
438–442.
32. Suzuki T., Kato H., Tsuda M., Suzuki H. and Misawa M. (1999) Effects of the non-competitive NMDA receptor antagonist ifenprodil on the morphineinduced place preference in mice. Life Sci. 64, 151–156.
33. Suzuki T., Kato H., Aoki T., Tsuda M., Narita M. and Misawa M. (2000) Effects of the non-competitive NMDA receptor antagonist ketamine on the
morphine-induced place preference in mice. Life Sci. 67, 383–389.
34. Tingley W. G., Roche K. W., Thompson A. K. and Huganir R. L. (1993) Regulation of NMDA receptor phosphorylation by alternative splicing of the
C-terminal domain. Nature 364, 70–73.
35. Trujillo K. A. and Akil H. (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK801. Science 251, 85–87.
36. Tsuda M., Suzuki T. and Misawa M. (1997) Role of the NMDA receptor complex in the DMCM-induced seizure in mice. NeuroReport 8, 603–606.
37. Tzschentke T. M. and Schmidt W. J. (1995) N-Methyl-d-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats.
Neurosci. Lett. 193, 37–40.
38. Varney M. A., Jachec C., Deal C., Hess S. D., Daggett L. P., Skvoretz R., Urcan M., Morrison J. H., Moran T., Johonson E. C. and Velicelebi G. (1996)
Stable expression and characterization of recombinant human heteromeric N-methyl-d-aspartate receptor subtypes NMDAR1A/2A and NMDAR1A/2B
in mammalian cells. J. Pharmac. exp. Ther. 279, 367–378.
39. Wagner D. A. and Leonard J. P. (1996) Effect of protein kinase-C activation on the Mg21-sensitivity of cloned NMDA receptor. Neuropharmacology 35,
29–36.
40. Watanabe M., Inoue Y., Sakimura K. and Mishina M. (1992) Developmental changes in distribution of NMDA receptor channel subunit mRNAs.
NeuroReport 3, 1138–1140.
41. Watanabe M., Inoue Y., Sakimura K. and Mishina M. (1993) Distinct distributions of five N-methyl-d-aspartate receptor channel subunit mRNAs in the
forebrain. J. comp. Neurol. 338, 377–390.
42. Williams K. (1993) Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric
receptors. Molec. Pharmac. 44, 851–859.
43. Yamazaki M., Mori H., Araki K., Mori K. J. and Mishina M. (1992) Cloning, expression and modulation of a mouse NMDA receptor subunit. Fedn Eur.
biochem. Scos Lett. 300, 39–45.
